Literature DB >> 10403044

Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles.

M T Peracchia1, S Harnisch, H Pinto-Alphandary, A Gulik, J C Dedieu, D Desmaële, J d'Angelo, R H Müller, P Couvreur.   

Abstract

The in vitro protein-rejecting properties of PEG-coated polyalkylcyanoacrylate (PACA) nanoparticles were for the first time visualized after freeze-fracture of the nanoparticles pre-incubated with fibrinogen as a model blood protein. The reduced protein association to the nanoparticles was evidenced also by two-dimensional PAGE after incubation of the nanoparticles with human plasma. In vivo experiments showed the 'stealth' long-circulating properties of the PEGylated nanoparticles after intravenous administration to mice. Thus, the images obtained after nanoparticle-protein incubation were predictive of the behavior observed in vivo. In conclusion, freeze-fracture analysis represents a novel and original qualitative approach to investigate the interactions between proteins and particulate systems.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403044     DOI: 10.1016/s0142-9612(99)00021-6

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  36 in total

Review 1.  Action and reaction: the biological response to siRNA and its delivery vehicles.

Authors:  Rosemary L Kanasty; Kathryn A Whitehead; Arturo J Vegas; Daniel G Anderson
Journal:  Mol Ther       Date:  2012-01-17       Impact factor: 11.454

2.  PEGylation of model drug carriers enhances phagocytosis by primary human neutrophils.

Authors:  William J Kelley; Catherine A Fromen; Genesis Lopez-Cazares; Omolola Eniola-Adefeso
Journal:  Acta Biomater       Date:  2018-09-06       Impact factor: 8.947

Review 3.  Non-viral therapeutic approaches to ocular diseases: An overview and future directions.

Authors:  Rahel Zulliger; Shannon M Conley; Muna I Naash
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

4.  Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles.

Authors:  Marina A Dobrovolskaia; Anil K Patri; Jiwen Zheng; Jeffrey D Clogston; Nader Ayub; Parag Aggarwal; Barry W Neun; Jennifer B Hall; Scott E McNeil
Journal:  Nanomedicine       Date:  2008-12-13       Impact factor: 5.307

5.  Loading of tetanus toxoid to biodegradable nanoparticles from branched poly(sulfobutyl-polyvinyl alcohol)-g-(lactide-co-glycolide) nanoparticles by protein adsorption: a mechanistic study.

Authors:  Tobias Jung; Walter Kamm; Armin Breitenbach; Gerhard Klebe; Thomas Kissel
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

6.  A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles.

Authors:  E Garcia-Garcia; S Gil; K Andrieux; D Desmaële; V Nicolas; F Taran; D Georgin; J P Andreux; F Roux; P Couvreur
Journal:  Cell Mol Life Sci       Date:  2005-06       Impact factor: 9.261

Review 7.  Factors affecting the clearance and biodistribution of polymeric nanoparticles.

Authors:  Frank Alexis; Eric Pridgen; Linda K Molnar; Omid C Farokhzad
Journal:  Mol Pharm       Date:  2008-08-04       Impact factor: 4.939

8.  Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients.

Authors:  Katayoun Derakhshandeh; Marzieh Soheili; Simin Dadashzadeh; Reza Saghiri
Journal:  Int J Nanomedicine       Date:  2010-08-09

9.  Polybutylcyanoacrylate nanoparticles and drugs of the platinum family: last status.

Authors:  Dashti Rahmat Abadi Fatemeh; Hasan Ebrahimi Shahmabadi; Anita Abedi; Seyed Ebrahim Alavi; Fatemeh Movahedi; Maedeh Koohi Moftakhari Esfahani; Tahereh Zadeh Mehrizi; Azim Akbarzadeh
Journal:  Indian J Clin Biochem       Date:  2013-07-23

10.  Investigation of polymeric amphiphilic nanoparticles as antitumor drug carriers.

Authors:  Jing Zhang; Xi Guang Chen; Cheng Sheng Liu; Hyun Jin Park
Journal:  J Mater Sci Mater Med       Date:  2008-12-13       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.